Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Kardiologiia ; 43(10): 72-5, 2003.
Article in Russian | MEDLINE | ID: mdl-14593358

ABSTRACT

Nebivolol was given for 8 weeks to 34 menopausal women with grade 1 and 2 hypertension. Monotherapy was effective in 66,7% of patients, while in other patients combination with hydrochlorothiazide (12.5 mg) was required. The use of nebivolol was associated with decreased rate and severity of vasomotion reactions and thus with positive effect on menopausal syndrome. Nebivolol appeared to be safe and metabolically neutral.


Subject(s)
Antihypertensive Agents/therapeutic use , Benzopyrans/therapeutic use , Ethanolamines/therapeutic use , Hypertension/drug therapy , Age Factors , Antihypertensive Agents/administration & dosage , Benzopyrans/administration & dosage , Diuretics , Drug Therapy, Combination , Ethanolamines/administration & dosage , Female , Humans , Hydrochlorothiazide/administration & dosage , Hydrochlorothiazide/therapeutic use , Menopause , Middle Aged , Nebivolol , Postmenopause , Sodium Chloride Symporter Inhibitors/administration & dosage , Sodium Chloride Symporter Inhibitors/therapeutic use , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...